• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

冠状动脉生物可吸收血管支架成功治疗复发性颈动脉支架内再狭窄及药物洗脱球囊治疗失败：一例报告

Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report.

作者信息

Giordano Arturo, Ferraro Paolo, Corcione Nicola, Messina Stefano, Maresca Gennaro, Coscioni Enrico, Biondi-Zoccai Giuseppe

机构信息

Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy; Unità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano, Italy.

Division of Cardiac Surgery, San Giovanni di Dio e Ruggì D'Aragona Hospital, Salerno, Italy.

出版信息

Int J Surg Case Rep. 2016;21:78-82. doi: 10.1016/j.ijscr.2016.02.035. Epub 2016 Feb 27.

DOI:10.1016/j.ijscr.2016.02.035
PMID:26945488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4802336/
Abstract

INTRODUCTION

Carotid in-stent restenosis is associated with substantial risk of recurrent restenosis, even after drug-eluting balloon usage.

PRESENTATION OF CASE

We hereby report the case of a patient with recurrent carotid in-stent restenosis and drug-eluting balloon failure treated with a coronary bioresorbable vascular scaffold, achieving a satisfactory acute and long-term result, as disclosed by duplex ultrasound scan performed more than 1 year after the procedure.

DISCUSSION/CONCLUSION: While awaiting for external validation, this clinical vignette supports expanding the armamentarium of endovascular specialists focusing on carotid artery disease, while providing further proof of the safety and efficacy of current bioresorbable vascular scaffolds.

摘要

引言

即使使用了药物洗脱球囊，颈动脉支架内再狭窄仍与较高的再狭窄复发风险相关。

病例介绍

我们在此报告一例复发性颈动脉支架内再狭窄且药物洗脱球囊治疗失败的患者，采用冠状动脉生物可吸收血管支架治疗后，经术后1年多的双功超声扫描显示，取得了满意的近期和长期效果。

讨论/结论：在等待外部验证的同时，该临床病例支持扩大专注于颈动脉疾病的血管介入专家的器械库，同时进一步证明了当前生物可吸收血管支架的安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/740e48ec5bbb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/0af055307da4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/59ce3ec3be0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/740e48ec5bbb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/0af055307da4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/59ce3ec3be0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d05/4802336/740e48ec5bbb/gr3.jpg

相似文献

1
Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report.冠状动脉生物可吸收血管支架成功治疗复发性颈动脉支架内再狭窄及药物洗脱球囊治疗失败：一例报告
Int J Surg Case Rep. 2016;21:78-82. doi: 10.1016/j.ijscr.2016.02.035. Epub 2016 Feb 27.
2
Three-year follow-up optical coherence tomography of under-expanded drug-eluting stent in-stent restenosis treated with ABSORB bioresorbable vascular scaffold following ultra-high pressure pre-dilatation.超高压力预扩张后使用ABSORB生物可吸收血管支架治疗的未充分扩张药物洗脱支架内再狭窄的三年随访光学相干断层扫描
J Cardiol Cases. 2017 Nov 10;17(1):4-8. doi: 10.1016/j.jccase.2017.08.015. eCollection 2018 Jan.
3
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
4
Bioresorbable vascular scaffold for coronary in-stent restenosis: a novel concept.用于冠状动脉支架内再狭窄的生物可吸收血管支架：一个新概念。
Indian Heart J. 2014 Jul-Aug;66(4):459-61. doi: 10.1016/j.ihj.2014.05.016. Epub 2014 Jun 10.
5
Restenosis of a drug eluting stent on the previous bioresorbable vascular scaffold successfully treated with a drug-coated balloon: A case report.使用药物涂层球囊成功治疗先前生物可吸收血管支架上的药物洗脱支架再狭窄：一例报告。
World J Clin Cases. 2021 Jan 26;9(3):758-763. doi: 10.12998/wjcc.v9.i3.758.
6
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
7
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).生物可吸收血管支架与依维莫司洗脱支架或药物洗脱球囊治疗冠状动脉支架内再狭窄的比较：倾向性评分匹配比较的 1 年随访（BIORESOLVE-ISR 研究）。
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):668-677. doi: 10.1002/ccd.27473. Epub 2018 Jan 22.
8
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.药物洗脱球囊血管成形术治疗难治性复发性颈动脉支架内再狭窄的长期结果
J Endovasc Ther. 2014 Oct;21(5):671-7. doi: 10.1583/14-4715MR.1.
9
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.生物可吸收血管支架治疗支架内再狭窄患者：RIBS VI 研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1841-1851. doi: 10.1016/j.jcin.2017.06.064. Epub 2017 Aug 30.
10
Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis.药物洗脱球囊治疗颈动脉支架置入术后复发性狭窄：单中心回顾性分析
Neuroradiology. 2018 Jan;60(1):81-87. doi: 10.1007/s00234-017-1935-7. Epub 2017 Oct 20.

引用本文的文献

1
The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis.靶向载双响应性 pH 和 ROS 纳米药物在防治血管再狭窄中的应用。
J Healthc Eng. 2021 Nov 26;2021:3982158. doi: 10.1155/2021/3982158. eCollection 2021.
2
Bio-Performance of Hydrothermally and Plasma-Treated Titanium: The New Generation of Vascular Stents.水热和等离子体处理钛的生物性能：新一代血管支架。
Int J Mol Sci. 2021 Nov 1;22(21):11858. doi: 10.3390/ijms222111858.
3
Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging.

本文引用的文献

1
Successful Treatment of a Subclavian Artery Stenosis With a Coronary Bioresorbable Vascular Scaffold.使用冠状动脉生物可吸收血管支架成功治疗锁骨下动脉狭窄
J Endovasc Ther. 2016 Aug;23(4):653-6. doi: 10.1177/1526602816649370. Epub 2016 May 10.
2
Endovascular Therapy for Infrainguinal Artery Disease With Coronary Devices: A Retrospective Observational Study Comparing Drug-Eluting Stents Versus Bioresorbable Vascular Scaffolds.使用冠状动脉器械进行的股腘动脉疾病血管内治疗：一项比较药物洗脱支架与生物可吸收血管支架的回顾性观察研究。
Angiology. 2017 Jan;68(1):59-66. doi: 10.1177/0003319716637802. Epub 2016 Mar 15.
3
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.
依维莫司洗脱生物可吸收血管支架与依维莫司洗脱支架治疗冠状动脉慢性完全闭塞的疗效长期随访：冠状动脉内成像引导的比较研究
Egypt Heart J. 2020 Oct 21;72(1):72. doi: 10.1186/s43044-020-00104-x.
4
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis.生物可吸收血管支架与药物洗脱支架治疗冠心病的Meta分析
J Cardiothorac Surg. 2020 Jan 28;15(1):26. doi: 10.1186/s13019-020-1041-5.
5
Bioresorbable Vascular Scaffolds in Interventional Neuroradiology.介入神经放射学中的生物可吸收血管支架。
Clin Neuroradiol. 2018 Dec;28(4):585-592. doi: 10.1007/s00062-017-0609-5. Epub 2017 Jul 26.
颈动脉狭窄支架置入术与动脉内膜切除术的长期结果
N Engl J Med. 2016 Mar 17;374(11):1021-31. doi: 10.1056/NEJMoa1505215. Epub 2016 Feb 18.
4
Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis.无症状性颈动脉狭窄支架治疗与手术治疗随机试验
N Engl J Med. 2016 Mar 17;374(11):1011-20. doi: 10.1056/NEJMoa1515706. Epub 2016 Feb 17.
5
Commentary: Cilostazol and Carotid Stenting: A Merry Marriage?评论：西洛他唑与颈动脉支架置入术：美满姻缘？
J Endovasc Ther. 2016 Feb;23(1):196-8. doi: 10.1177/1526602815619405.
6
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.依维莫司洗脱生物可吸收支架治疗冠状动脉疾病。
N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.
7
Bioresorbable Vascular Scaffolds--Will Promise Become Reality?生物可吸收血管支架——承诺会成为现实吗？
N Engl J Med. 2015 Nov 12;373(20):1969-71. doi: 10.1056/NEJMe1512331. Epub 2015 Oct 12.
8
Commentary: Carotid Stent Design: More Than Meets the Eye?评论：颈动脉支架设计：表象之下另有乾坤？
J Endovasc Ther. 2015 Oct;22(5):798-800. doi: 10.1177/1526602815600161.
9
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?吸收性生物可吸收血管支架：5年临床经验后我们学到了什么？
Int J Cardiol. 2015 Dec 15;201:129-36. doi: 10.1016/j.ijcard.2015.07.101. Epub 2015 Aug 7.
10
Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis.颈动脉内膜剥脱术后再狭窄患者在颈动脉支架置入术前进行药物涂层球囊扩张。
J Endovasc Ther. 2015 Apr;22(2):212-6. doi: 10.1177/1526602815573498.